FDA Inspection 1093600 — The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services
The FDA completed an inspection of The Northeast Philadelphia Donor Center American Red Cross Penn Jersey Region Biomedical Services on May 24, 2019 in Philadelphia, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 24, 2019
- Fiscal Year
- 2019
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Philadelphia, PA (United States)